660 related articles for article (PubMed ID: 18977094)
21. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
[TBL] [Abstract][Full Text] [Related]
22. Current management of brain metastases, with a focus on systemic options.
Langer CJ; Mehta MP
J Clin Oncol; 2005 Sep; 23(25):6207-19. PubMed ID: 16135488
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of late neurologic adverse events in patients with brain metastases from non-small cell lung cancer.
Nieder C; Astner ST; Grosu AL; Molls M
Anticancer Res; 2007; 27(3B):1701-4. PubMed ID: 17595800
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
25. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
[TBL] [Abstract][Full Text] [Related]
26. Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points.
Mehta MP; Shapiro WR; Glantz MJ; Patchell RA; Weitzner MA; Meyers CA; Schultz CJ; Roa WH; Leibenhaut M; Ford J; Curran W; Phan S; Smith JA; Miller RA; Renschler MF
J Clin Oncol; 2002 Aug; 20(16):3445-53. PubMed ID: 12177105
[TBL] [Abstract][Full Text] [Related]
27. Multimodality management of non-small cell lung cancer patients with brain metastases.
Ricciardi S; de Marinis F
Curr Opin Oncol; 2010 Mar; 22(2):86-93. PubMed ID: 20009927
[TBL] [Abstract][Full Text] [Related]
28. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51.
Laack NN; Ballman KV; Brown PB; O'Neill BP;
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1429-39. PubMed ID: 16863926
[TBL] [Abstract][Full Text] [Related]
29. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
30. Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy.
Zabel A; Debus J
Lung Cancer; 2004 Aug; 45 Suppl 2():S247-52. PubMed ID: 15552806
[TBL] [Abstract][Full Text] [Related]
31. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
32. Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases.
Kocher M; Eich HT; Semrau R; Güner SA; Müller RP
Strahlenther Onkol; 2005 Jan; 181(1):20-5. PubMed ID: 15660189
[TBL] [Abstract][Full Text] [Related]
33. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
Li J; Bentzen SM; Li J; Renschler M; Mehta MP
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
[TBL] [Abstract][Full Text] [Related]
34. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
Carolan H; Sun AY; Bezjak A; Yi QL; Payne D; Kane G; Waldron J; Leighl N; Feld R; Burkes R; Keshavjee S; Shepherd F
Lung Cancer; 2005 Jul; 49(1):109-15. PubMed ID: 15949596
[TBL] [Abstract][Full Text] [Related]
35. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
36. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.
Rades D; Meyners T; Veninga T; Stalpers LJ; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):404-8. PubMed ID: 20171794
[TBL] [Abstract][Full Text] [Related]
37. Comparison of different treatment approaches for one to two brain metastases in elderly patients.
Rades D; Pluemer A; Veninga T; Schild SE
Strahlenther Onkol; 2008 Nov; 184(11):565-71. PubMed ID: 19016014
[TBL] [Abstract][Full Text] [Related]
38. Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis.
Rades D; Kieckebusch S; Haatanen T; Lohynska R; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1319-24. PubMed ID: 18374222
[TBL] [Abstract][Full Text] [Related]
39. Brain metastases: current management and new developments.
Soffietti R; Rudà R; Trevisan E
Curr Opin Oncol; 2008 Nov; 20(6):676-84. PubMed ID: 18841050
[TBL] [Abstract][Full Text] [Related]
40. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
